Clinical Trial Results:
Combination therapy of insulin glargine and sitagliptin in patients with type 2 diabetes not adequately controlled by a previous treatment with metformin and either insulin glargine or sitagliptin (Extension of the study LANTU_C_02761).
Summary
|
|
EudraCT number |
2008-000521-19 |
Trial protocol |
NL PT AT ES GB |
Global completion date |
09 Sep 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Apr 2016
|
First version publication date |
06 Apr 2016
|
Other versions |
|
Summary report(s) |
EXT_LANTU_C_02761 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.